Literature DB >> 8359916

Expression of the Pasteurella haemolytica leukotoxin is inhibited by a locus that encodes an ATP-binding cassette homolog.

S K Highlander1, E A Wickersham, O Garza, G M Weinstock.   

Abstract

Multicopy and single-copy chromosomal fusions between the Pasteurella haemolytica leukotoxin regulatory region and the Escherichia coli beta-galactosidase gene have been constructed. These fusions were used as reporters to identify and isolate regulators of leukotoxin expression from a P. haemolytica cosmid library. A cosmid clone, which inhibited leukotoxin expression from multicopy and single-copy protein fusions, was isolated and found to contain the complete leukotoxin gene cluster plus additional upstream sequences. The locus responsible for inhibition of expression from leukotoxin-beta-galactosidase fusions was mapped within these upstream sequences, by transposon mutagenesis with Tn5, and its DNA sequence was determined. The inhibitory activity was found to be associated with a predicted 440-amino-acid reading frame (lapA) that lies within a four-gene arginine transport locus. LapA is predicted to be the nucleotide-binding component of this transport system and shares homology with the Clp family of proteases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8359916      PMCID: PMC281098          DOI: 10.1128/iai.61.9.3942-3951.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Transposition and fusion of the lac genes to selected promoters in Escherichia coli using bacteriophage lambda and Mu.

Authors:  M J Casadaban
Journal:  J Mol Biol       Date:  1976-07-05       Impact factor: 5.469

2.  Two periplasmic transport proteins which interact with a common membrane receptor show extensive homology: complete nucleotide sequences.

Authors:  C F Higgins; G F Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

3.  Replicon fusions promoted by the inverted repeats of Tn5. The right repeat is an insertion sequence.

Authors:  R R Isberg; M Syvanen
Journal:  J Mol Biol       Date:  1981-07-25       Impact factor: 5.469

Review 4.  The use of transposon Tn5 mutagenesis in the rapid generation of correlated physical and genetic maps of DNA segments cloned into multicopy plasmids--a review.

Authors:  F J de Bruijn; J R Lupski
Journal:  Gene       Date:  1984-02       Impact factor: 3.688

5.  Lambda replacement vectors carrying polylinker sequences.

Authors:  A M Frischauf; H Lehrach; A Poustka; N Murray
Journal:  J Mol Biol       Date:  1983-11-15       Impact factor: 5.469

6.  Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes.

Authors:  P E Shewen; B N Wilkie
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

7.  DNA sequence of the Pasteurella haemolytica leukotoxin gene cluster.

Authors:  S K Highlander; M Chidambaram; M J Engler; G M Weinstock
Journal:  DNA       Date:  1989 Jan-Feb

8.  Construction of a broad host range cosmid cloning vector and its use in the genetic analysis of Rhizobium mutants.

Authors:  A M Friedman; S R Long; S E Brown; W J Buikema; F M Ausubel
Journal:  Gene       Date:  1982-06       Impact factor: 3.688

9.  Construction and characterization of new cloning vehicles. I. Ampicillin-resistant derivatives of the plasmid pMB9.

Authors:  F Bolivar; R L Rodriguez; M C Betlach; H W Boyer
Journal:  Gene       Date:  1977       Impact factor: 3.688

10.  Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold.

Authors:  J E Walker; M Saraste; M J Runswick; N J Gay
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  9 in total

1.  Enterococcus faecalis antigens in human infections.

Authors:  Y Xu; L Jiang; B E Murray; G M Weinstock
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  Generation of targeted nonpolar gene insertions and operon fusions in Pasteurella haemolytica and creation of a strain that produces and secretes inactive leukotoxin.

Authors:  N D Fedorova; S K Highlander
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Use of operon fusions in Mannheimia haemolytica to identify environmental and cis-acting regulators of leukotoxin transcription.

Authors:  A M Marciel; S K Highlander
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Genetic and transcriptional analysis of flgB flagellar operon constituents in the oral spirochete Treponema denticola and their heterologous expression in enteric bacteria.

Authors:  H F Heinzerling; M Olivares; R A Burne
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  A putative leucine zipper activator of Pasteurella haemolytica leukotoxin transcription and the potential for modulation of its synthesis by slipped-strand mispairing.

Authors:  S K Highlander; V T Hang
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

6.  Identification and characterization of HsIV HsIU (ClpQ ClpY) proteins involved in overall proteolysis of misfolded proteins in Escherichia coli.

Authors:  D Missiakas; F Schwager; J M Betton; C Georgopoulos; S Raina
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

7.  Pasteurella haemolytica serotype 2 contains the gene for a noncapsular serotype 1-specific antigen.

Authors:  C T Gonzalez; S K Maheswaran; M P Murtaugh
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

8.  Isolation of Pasteurella haemolytica leukotoxin mutants.

Authors:  M Chidambaram; B Sharma; S F Petras; C P Reese; S Froshauer; G M Weinstock
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

9.  Analysis of gene order data supports vertical inheritance of the leukotoxin operon and genome rearrangements in the 5' flanking region in genus Mannheimia.

Authors:  Jesper Larsen; Peter Kuhnert; Joachim Frey; Henrik Christensen; Magne Bisgaard; John E Olsen
Journal:  BMC Evol Biol       Date:  2007-10-03       Impact factor: 3.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.